08Aug 2018

PRIAPISM AND CHRONIC MYELOGENOUS LEUKEMIA.

  • Cardiology, Mayo Clinic, Rochester, USA, 802 1st ST SW, Rochester, MN, USA.
  • Observer In Internal Medicine, Baylor Saint Luke's Medical Center, Houston, USA.
  • Internal Medicine, Kamineni Institute of Medical Sciences, Narketpally, IND.
  • Internal Medicine, Harvard Medical College/Beth Israel Deaconess Medical Center, Boston, USA
  • Internal Medicine, Fatima Jinnah Medical University, High Point, USA.
  • Oncology, Mayo Clinic, Rochester, MN, USA.
  • Internal Medicine, Liaquat University of Medical and Health Sciences Hospital Jamshoro Sindh Pakistan., Jamshoro, PAK.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Chronic myeloid leukemia (CML) is a cancer of the white blood cells and the bone marrow. It is characterized by an increased and unregulated growth of myeloid cells in the bone marrow and accumulation of these cells in the blood. There are three stages of CML, and most patients are diagnosed incidentally with an elevated white blood cell count seen on the complete blood count (CBC). Occasionally, CML patients present with upper quadrant pain due to hepatosplenomegaly. An enlarged spleen may put pressure on the stomach, causing loss of appetite and weight loss. CML patients may also present with fever, night sweats, bleeding, or petechiae. An initial presentation of the CML patient with priapism is very unusual and rare. In this case report, we are documenting a case of a 22-year-old man who presented with a persistent painful erection of the penis for four days. After emergency treatment for the priapism, the patient underwent multiple investigations including blood morphology, bone marrow aspiration, and BCR-ABL molecular testing, which confirmed the diagnosis of CML. The purpose of this study is to highlight the rare presentation of CML and the importance of diagnosing the underlying cause responsible for the acute presentation.


  1. Faderl S, Talpaz M, Estrov Z, O'brien S, Kurzrock R, Kantarjian HM : The biology of chronic myeloid leukemia. N Engl J Med. 1999, 341:164-72 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10403855DOI: 1056/NEJM199907153410306
  2. Sheribman SM, Gee TS, Grabstold H: Management of Priapism in patients with chronic granulocytic leukemia. J Urol. 1974, 111:786-788. PMID: https://www.ncbi.nlm.nih.gov/pubmed/4524674DOI: 1016/S0022-5347(17)60075-2
  3. Montague DK, Jarow J, Broderick GA et al.: American Urological Association guideline on the management of priapism. J Urol. 2003, 170:1318-1324. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14501756DOI: 1097/01.ju.0000087608.07371.ca
  4. Eland, I.A., van der Lei, J., Stricker B.H. &Sturkenboom, M.J: Incidence of priapism in the general population . Urology. 2001, 57:970-972. PMID:https://www.ncbi.nlm.nih.gov/pubmed/11337305DOI: 1016/S0090-4295(01)00941-4
  5. Mulhall JP, Honig SC: Priapism: etiology and management . AcadEmerg Med. 1996, 3:810-816. PMID: https://www.ncbi.nlm.nih.gov/pubmed/8853679DOI: 1111/j.1553-2712.1996.tb03520.x
?

[Wajih Ullah M, Rehman A, Cheeti A, Siddiq W, Latif WA, Prasai K and Bai Joti. (2018); PRIAPISM AND CHRONIC MYELOGENOUS LEUKEMIA. Int. J. of Adv. Res. 6 (Aug). 144-146] (ISSN 2320-5407). www.journalijar.com


Muhammad Wajih Ullah
Mayo Clinic, Rochester, MN

DOI:


Article DOI: 10.21474/IJAR01/7501      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7501